January 18th 2021, 7:00pm
The Food and Drug Administration has had a busy winter so far, approving several new agents to treat a variety of cancers. Here are seven recent approvals that patients with cancer may have missed.
January 14th 2021, 8:00pm
Quality of life improved in patients treated with Darzalex, Revlimid and dexamethasone compared with Revlimid and dexamethasone, and were present regardless of age, functional status and the depth of their treatment response.
January 13th 2021, 10:00pm
Melflufen with dexamethasone was an effective treatment option for patients with relapsed or refractory multiple myeloma previously treated with a specific chemotherapy drug and/or an anti-CD38 monoclonal antibody.
January 7th 2021, 5:00pm
A caregiver discusses with her granddaughter the cancer diagnosis and treatment of a loved one.
December 30th 2020, 7:00pm
The Food and Drug Administration lifted a clinical hold on the MELANI-01 trial, evaluating UCARTCS1A, a CAR T-cell product in patients with relapsed or refractory multiple myeloma.
December 29th 2020, 10:00pm
In an interview with CURE®, Dr. Irene M. Ghobrial discussed smoldering myeloma, a precursor condition that may progress to multiple myeloma, how to proceed if diagnosed with the condition and the available opportunities to participate in clinical trials to learn more.
December 27th 2020, 3:00pm
Here are the top 10 episodes of the “CURE Talks Cancer” podcast from 2020.
December 21st 2020, 4:00pm
This treatment strategy contributed to a median progression-free survival of 13.93 months compared with 9.46 months in those treated with Velcade and dexamethasone.
December 18th 2020, 5:12pm
This treatment regimen of Xpovio with Velcade, approved for patients with multiple myeloma previously treated with at least one therapy, provides another option for patients with multiple myeloma to potentially close the treatment gap.
December 16th 2020, 7:00pm
Advancements in the diagnosis and staging of multiple myeloma continue to shape treatment decisions and improve outcomes.
Recent Cancer Diagnosis Associated With Increased Risk of COVID-19, Especially in Black Patients
National Organization Recommends COVID-19 Vaccine for Patients With Cancer
How To Live In The Present As Cancer Survivors
Opdivo Plus Yervoy Improves Survival for Patients with Rare Form of Eye Cancer
